Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 6, 2009, Pages

  Frisbee, Jefferson C ^a,b   Hollander, John M ^a   Brock, Robert W ^a   Yu, Han Gang ^a   Boegehold, Matthew A ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Microcirculation; Obesity; Peripheral vascular disease; Regional blood flow

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; ARACHIDONIC ACID; PHENYLEPHRINE; PROSTAGLANDIN H2; TEMPOL; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTERY PERFUSION; ARTICLE; BLOOD VESSEL REACTIVITY; CELL HETEROGENEITY; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HYPOXIA; INTESTINE PRESSURE; ISCHEMIA; MALE; METABOLIC SYNDROME X; MUSCLE CONTRACTION; MUSCLE PERFUSION; NEWBORN; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; VASODILATATION;

ADENOSINE; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC FIBERS; ANIMALS; ANOXIA; ANTIOXIDANTS; ARACHIDONIC ACID; ARTERIOLES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HINDLIMB; HYPEREMIA; MALE; METABOLIC SYNDROME X; MICROCIRCULATION; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; OBESITY; OXIDATIVE STRESS; RATS; RATS, ZUCKER; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 67049134549     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00096.2009     Document Type: Article

References (39)

1. Baker M, Wayland H. On-line volume-flow rates and velocity profile measurements for blood in microvessels. Microvasc Res 7: 131-143, 1974.
2. Baumbach GL, Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension 21: 816-826, 1993. (Pubitemid 23171645)
3. Bohlen HG. Protein kinase beta II in Zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation. Am J Physiol Heart Circ Physiol 286: H492-H497, 2004. (Pubitemid 38140328)
4. Cannon CP. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin Cornerstone 8: 11-28, 2007.
5. Chen D, Wang MW. Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7: 307-317, 2005. (Pubitemid 40916572)
6. Domeier TL, Segal SS. Electromechanical and pharmaco-mechanical signaling pathways for conducted vasodilatation along endothelium of hamster feed arteries. J Physiol 579: 175-186, 2007. (Pubitemid 46243404)
7. Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, Bunker SJ, Best JD, Vartiainen E, Kai Lo S, Janus ED Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care 31: 2368-2373, 2008.
8. Emerson GG, Segal SS. Electrical activation of endothelium evokes vasodilation and hyperpolarization along hamster feed arteries. Am J Physiol Heart Circ Physiol 280: H160-H167, 2001. (Pubitemid 32493096)
9. Ford ES, Mokdad AH. Epidemiology of obesity in the Western hemisphere. J Clin Endocrinol Metab 93, Suppl 1: S1-S8, 2008.
10. Frisbee JC. Enhanced arteriolar α-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 97: 764-772, 2004. (Pubitemid 38963153)
11. Frisbee JC. Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285: R1124-R1134, 2003. (Pubitemid 37296365)
12. Frisbee JC. Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 285: H104-H111, 2003. (Pubitemid 36736420)
13. Frisbee JC, Maier KG, Stepp DW. Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol 283: H2160-H2168, 2002. (Pubitemid 35345915)
14. Frisbee JC, Maier KG, Falck JR, Roman RJ, Lombard JH. Integration of hypoxic dilation signaling pathways for skeletal muscle resistance arteries. Am J Physiol Regul Integr Comp Physiol 283: R309-R319, 2002. (Pubitemid 34863877)
15. Frisbee JC, Stepp DW. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive, diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281: H1304-H1311, 2001. (Pubitemid 32879270)
16. Frisbee JC. Impaired dilation of skeletal muscle microvessels to reduced oxygen tension in diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 281: H1568-H1574, 2001. (Pubitemid 32948200)
17. Goodwill AG, James ME, Frisbee JC. Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. Am J Physiol Heart Circ Physiol 295: H1522-H1528, 2008.
18. Guerre-Millo M. Regulation of ob gene and overexpression in obesity. Biomed Pharmacother 51: 318-323, 1997. (Pubitemid 27423756)
19. Kannan H, Thompson S, Bolge SC. Economic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertension among individuals who are overweight or obese. J Occup Environ Med 50: 542-549, 2008.
20. Lesniewski LA, Donato AJ, Behnke BJ, Woodman CR, Laughlin MH, Ray CA, Delp MD. Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am J Physiol Heart Circ Physiol 294: H1840-H1850, 2008.
21. Li C, Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM. Trends in hyperinsulinemia among nondiabetic adults in the US. Diabetes Care 29: 2396-2402, 2006. (Pubitemid 44912242)
22. Liu Y, Fredricks KT, Roman RJ, Lombard JH. Response of resistance arteries to reduced PO2 and vasodilators during hypertension and elevated salt intake. Am J Physiol Heart Circ Physiol 273: H869-H877, 1997. (Pubitemid 27392243)
23. Messina EJ, Sun D, Koller A, Wolin MS, Kaley G. Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle. Circ Res 71: 790-796, 1992.
24. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 93, Suppl 1: S9-S30, 2008.
25. Naik JS, Xiang L, Hodnett BL, Hester RL. α-Adrenoceptor-mediated vasoconstriction is not involved in impaired functional vasodilation in the obese Zucker rat. Clin Exp Pharmacol Physiol 35: 611-616, 2008.
26. Naik JS, Xiang L, Hester RL. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 290: R154-R161, 2006.
27. Nie H, Wu JL, Zhang M, Xu J, Zou MH. Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo. Diabetes 55: 3133-3141, 2006. (Pubitemid 44923653)
28. Schreiner W, Karch R, Neumann M, Neumann F, Roedler SM, Heinze G. Heterogeneous perfusion is a consequence of uniform shear stress in optimized arterial tree models. J Theor Biol 220: 285-301, 2003. (Pubitemid 36177365)
29. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation 12: 33-45, 2005. (Pubitemid 40450616)
30. Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J 156: 719-727, 2008.
31. Stepp DW, Pollock DM, Frisbee JC. Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 286: H964-H970, 2004. (Pubitemid 38248610)
32. Stepp DW, Frisbee JC. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 282: H816-H820, 2002. (Pubitemid 34654915)
33. Sun D, Huang A, Koller A, Kaley G. Flow-dependent dilation and myogenic constriction interact to establish the resistance of skeletal muscle arterioles. Microcirculation 2: 289-295, 1995.
34. Xiang L, Dearman J, Abram SR, Carter C, Hester RL. Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am J Physiol Heart Circ Physiol 294: H1658-H1666, 2008.
35. Xiang L, Naik JS, Abram SR, Hester RL. Chronic hyperglycemia impairs functional vasodilation via increasing thromboxane-receptor-mediated vasoconstriction. Am J Physiol Heart Circ Physiol 292: H231-H236, 2007. (Pubitemid 46105183)
36. Xiang L, Naik JS, Hodnett BL, Hester RL. Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 290: R134-R138, 2006.
37. Zhou W, Wang XL, Kaduce TL, Spector AA, Lee HC. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288: H2210-H2218, 2005. (Pubitemid 40604107)
38. Zou MH. Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82: 119-127, 2007. (Pubitemid 44911071)
39. Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97, 2004. (Pubitemid 39207182)